Pharmafile Logo

Premier Print & Promotions Ltd

Unique, inspirational and quality promotional products and print. If you are looking for promotional gifts to promote your business, product or event then Premier Print & Promotions is the perfect choice. With nearly twenty years experience in the promotional merchandise industry we are now in the Top 10 leading distributors and suppliers in the UK.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop great pharmaceutical brands. We do this by creating Pharmacohesion™.

View Profile

Innovative Trials

Innovative Trials is a leading global clinical trial patient recruitment company. With over 10 years’ of experience, Innovative Trials deploys ‘boots-on-the-ground’ recruitment experts in over 70 countries, addressing individual sites’…

View Profile

Company Details

Premier House,, Threshelfords Business Park, Inworth Road, Feering, Essex, CO5 9SE, United Kingdom
+44 (0)1376 574680

 Latest Content from PMHub 

World Orphan Drug Congress 2025 in Amsterdam

Press Releases | October 23, 2025 | Medscape Education

Medscape Education will make its debut at the World Orphan Drug Congress (WODC) 2025, taking place in Amsterdam, the Netherlands, October 28-29.

Leading the future of Intelligent Commercialization™: Where proprietary data, tech, and AI meet expert insight

Press Releases | October 20, 2025 | Inizio

Inizio is leading the way in Intelligent Commercialization™ by uniting proprietary AI-powered platforms, deep scientific expertise, and proven governance to unlock measurable, lasting value at every stage of commercialization.

HRW strengthens senior US team with two new Vice Presidents in Manhattan

HRW has announced the appointment of Tina Sallustio and Lauren O’Malley as Vice Presidents in its Manhattan office, reinforcing the agency’s senior leadership team.

New report, The participation equation, uncovers key drivers of patient engagement in clinical trials

Press Releases | October 16, 2025 | Cuttsy + Cuttsy

Cuttsy+Cuttsy’s new report, The participation equation, uncovers what drives patient engagement and retention in modern clinical trials through insights from over 700 participants and industry experts.

Are digital communications losing the human touch?

Are you looking to ensure digital communications for healthcare professionals and patients still include the human touch? Here's how.

From Burnout to Balance: New Campaign Focuses on the ‘Matters’ that are Really Affecting Our ‘Minds’ in Health Communications

Press Releases | October 13, 2025 | Fox&Cat

Launched on World Mental Health Day, Minds on Matters aims to highlight mental wellbeing challenges while showcasing practical solutions and positive change

Your Blueprint for Flawless Pharma Omnichannel

Press Releases | October 9, 2025 | Impetus Digital

Learn how to eliminate silos, transform data into actionable insights, and drive unparalleled efficiency across your key initiatives. Secure your spot in our free webinar, exclusive for life science professionals!

Build a KOL Community Virtually – Engaging Your Advisors Creatively

Go beyond formal meetings! Discover a creative way to build a virtual KOL community through ongoing discussion forums. Facilitate peer-to-peer best practice sharing and foster authentic, sustained relationships with your...

Resonant Group’s CEO celebrated for driving innovation and professional excellence across the healthcare communications sector

Resonant Group’s CEO celebrated for driving innovation and professional excellence across the healthcare communications sector

Uniphar On Track to Achieve SBTi Target of Halving Scope 1 and 2 Emissions by 2030

Press Releases | October 9, 2025 | Uniphar

[Dublin, 9th October 2025] Uniphar, a global leader in pharmaceutical and medtech solutions, is making progress towards its near-term Science Based Targets initiative (SBTi) goal of halving Scope 1 and...